sumi.news
Search
Following
Sign in
← Back to news
Markets
RSS Feed
sumi.news
Markets
Follow
Latest
Thu Jan 1
Gold and silver’s $7 trillion wipeout delivers a painful lesson about risk
14h
Y
What AI Predicts About the Future of the Stock Market — and Your Wallet
14h
Y
Plug Power Stock: A Deep-Value Investment or a Dangerous Holding?
14h
Y
Trump Just Sent This Nuclear Stock to New 10-Year Highs. Should You Buy Shares Now?
14h
Y
Trump’s plan to make housing affordable is faltering
14h
Y
Truist Raises Flywire (FLYW) PT to $17 Following FinTech Sector Preview
14h
Y
Truist Highlights Valuation Gap for PagerDuty (PD) Amid AI Market Divide
14h
Y
Mizuho Trims Rapid7 (RPD) PT to $16, Maintains Neutral Rating
14h
Y
Morgan Stanley Adopts Constructive 2026 Outlook for Sprout Social (SPT) as AI Risks Ease
14h
Y
Is Sonos Inc. (SONO) One of the Best Small Cap Tech Stocks to Invest in Now?
14h
Y
Goldman Sachs Assumes Penguin Solutions (PENG) Coverage with Buy Rating, $25 PT
14h
Y
MaxLinear (MXL) Q4 Revenue Jumps 48% Driven by Infrastructure and Data Center Demand
14h
Y
Morgan Stanley Upgrades Amplitude (AMPL) to Overweight, Raises PT to $16
14h
Y
B. Riley Raises Cohu (COHU) PT to $35 Amid Surging AI-Driven Demand
14h
Y
Citi Trims Progress Software (PRGS) PT to $54, Maintains Buy Rating
14h
Y
My 2 Favorite Stocks to Buy Right Now
14h
Y
Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?
14h
Y
Wall Street Bullish on BeOne Medicines AG (ONC) amid Robust Pipeline Development
14h
Y
AstraZeneca PLC (AZN)’s $15B China Expansion Fuels Long-Term Growth Outlook
14h
Y
Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone
14h
Y
IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook
14h
Y
Analysts Lift Ratings and Price Targets as Cencora, Inc. (COR)’s Growth Story Gains Momentum
14h
Y
Analysts See Pipeline Catalysts Driving Teva Pharmaceutical Industries Limited (TEVA)’s 2026 Growth Despite Revenue Headwinds
14h
Y
Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW)
14h
Y
Analyst Views Diverge as Alnylam Pharmaceuticals, Inc. (ALNY) Targets $5.1B Revenue and Long-Term Growth
14h
Y
CVS Health Corporation (CVS) Positioned for Long-Term Growth Amid Policy Shifts
14h
Y
AbbVie Inc. (ABBV) Balances Analyst Caution with Pipeline Progress and Long-Term Growth
14h
Y
Eli Lilly and Company (LLY) Expands U.S. Manufacturing and Advances Breakthrough Therapies
14h
Y
Werner Enterprises Closes $245M FirstFleet Deal, Targets $18M Synergies and Dedicated Growth
14h
Y
If You'd Invested $100 in Ford 5 Years Ago, Here's How Much You'd Have Today
14h
Y
'Big Short' Michael Burry Calls Tesla CEO Elon Musk 'Desperately Incentivized Futurist' Amid SpaceX Merger Reports: 'Elon Is An…'
14h
Y
My 5 Favorite Ultra-High-Yield Dividend Stocks to Buy for 2026
14h
Y
1 Underrated AI Stock to Buy and Hold for 10 Years
14h
Y
Nvidia CEO Huang denies he is unhappy with OpenAI, says 'huge' investment planned
14h
Y
If You'd Invested $1,000 In Micron Technology 42 Years Ago, Here's How Much You'd Have Today
15h
Y
Jaspreet Singh Says This Is the Biggest Investing Trap of 2026 — Should You Change Your Strategy?
15h
Y
‘Mr. Buffett, how can I make $30 billion?’: Warren Buffett’s answer reveals his 3 simple investing rules
15h
Y
Trump’s Dollar ‘Yo-Yo’ Has Stock Investors Looking Overseas
15h
Y
The CEO Steering Hyundai’s $26 Billion U.S. Bet—and Its Push Into Robots
15h
Y
Kevin O’Leary reveals the powerful payday tactic his mom used to build wealth. Make 10x your income without more work
15h
Y
Hyundai Motor CEO All-In on America
15h
Y
Is Figma Stock a Buy Now?
15h
Y
Piper Sandler Updates Its Outlook on Visa (V) Shares
15h
Y
Jim Cramer on Starbucks: “I Think This Turn Is Solid and Long-Lasting”
15h
Y
Jim Cramer on Lithium Americas: “We’re Going to Say It’s Too Speculative for Me”
15h
Y
Jim Cramer in Intuit: “I Think It Should Do Better”
15h
Y
Jim Cramer on Energy Transfer: “Very Inexpensive Stock, Great Pipeline Company”
15h
Y
Jim Cramer on Robinhood: “It Is a Buy”
15h
Y
Jim Cramer Highlights Teva Pharmaceutical’s Growth Under CEO Richard Francis
15h
Y
Jim Cramer Notes That Levi’s “Suffered From President Trump’s Trade War”
15h
Y
More →